|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
3 months to Mar 31, 2023
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| OPERATING ACTIVITIES | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Depreciation and amortization | |||||
| Stock-based compensation expense | |||||
| Gain on disposition of assets, net | |||||
| Gain due to benefit plan financing arrangement | |||||
| Deferred income tax provision | |||||
| Acquisition related employment costs | |||||
| Pension settlement charges | |||||
| Other non-cash adjustments | |||||
| (Increase) decrease in assets: | |||||
| Accounts receivable | |||||
| Income taxes receivable | |||||
| Inventories | |||||
| Prepaid expenses | |||||
| Other current assets | |||||
| Retirement plan assets | |||||
| Other non-current assets | |||||
| (Decrease) increase in liabilities: | |||||
| Accounts payable | |||||
| Income taxes payable | |||||
| Unearned revenue | |||||
| Accrued payroll and related expenses | |||||
| Pension liabilities | |||||
| Accrued insurance expenses | |||||
| Accrued state, local and other taxes | |||||
| Other accrued expenses | |||||
| Retirement plan liabilities | |||||
| Long-term accrued insurance expenses | |||||
| Other long-term liabilities | |||||
| Net cash provided by operating activities | |||||
| INVESTING ACTIVITIES | |||||
| Capital expenditures | |||||
| Proceeds from sale of assets | |||||
| Purchase of business | |||||
| Purchase of business, net of cash and debt assumed | |||||
| Proceeds from benefit plan financing arrangement | |||||
| Distribution from benefit plan financing arrangement | |||||
| Net cash used for investing activities | |||||
| FINANCING ACTIVITIES | |||||
| Payment of dividends | |||||
| Repayment of debt assumed at acquisition | |||||
| Cash paid for common stock purchased and retired | |||||
| Cash paid for finance lease | |||||
| Net cash used for financing activities | |||||
| Net (decrease) increase in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of period | |||||
| Cash and cash equivalents at end of period | |||||
| Supplemental cash flows disclosure: | |||||
| Income tax payments, net | |||||
| Interest paid | |||||
| Supplemental disclosure of noncash investing activities: | |||||
| Capital expenditures included in accounts payable |
Loading...